Vous n'êtes pas connecté
QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology across North America and Europe.
QIAGEN launches 100 new assays for QIAcuity. The newly launched assays are now available through the company???s GeneGlobe platform.
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays.
CosmoBlue Media has launched a theatrical distribution arm in Canada. The company, which has recently acquired Macademia and its brands Azoomee and Da...
BERY stands to gain from strength in its Consumer Packaging North America segment. The company's measures to reward its shareholders are also...
QIAGEN announces exclusive global commercial partnership with Bode Technology. Per the agreement, Bode will manage all commercial transactions for...
CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across 10...
BIO strategically expands its ddPCR platform while eyeing global expansion and benefiting from its clinical diagnostics arm.
The iconic beach club’s newly-opened restaurant, SIERRA, will now be serving a business lunch menu curated by Executive Head Chef Nasser Fouad...
The product expands NOK's Lightspan multi-gig fiber portfolio and enables operators to address various subscriber and application needs.